150 related articles for article (PubMed ID: 5763043)
1. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
[No Abstract] [Full Text] [Related]
2. Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Baker BR; Lourens GJ
J Med Chem; 1969 Jan; 12(1):101-4. PubMed ID: 5763002
[No Abstract] [Full Text] [Related]
3. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
Baker BR; Meyer RB
J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004
[No Abstract] [Full Text] [Related]
4. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
Baker BR; Meyer RB
J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
[No Abstract] [Full Text] [Related]
5. Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamido)phenoxymethyl]pyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):82-5. PubMed ID: 5763046
[No Abstract] [Full Text] [Related]
6. Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenz amido) phenoxymethyl] pyrimidine, an active-site-directed irreverisible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):82-5. PubMed ID: 5777842
[No Abstract] [Full Text] [Related]
7. Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):74-8. PubMed ID: 5763044
[No Abstract] [Full Text] [Related]
8. Irreversible enzyme inhibitors. CXL. Active-site-directed irreversible inhibitors derived from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Baker BR; Lourens GJ
J Med Chem; 1969 Jan; 12(1):95-101. PubMed ID: 5763050
[No Abstract] [Full Text] [Related]
9. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
[No Abstract] [Full Text] [Related]
10. Irreversible enzyme inhibitors. CXXXV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(p-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):79-81. PubMed ID: 5763045
[No Abstract] [Full Text] [Related]
11. Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
Baker BR; Vermeulen NM
J Med Chem; 1969 Jan; 12(1):89-91. PubMed ID: 5763048
[No Abstract] [Full Text] [Related]
12. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
[No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity.
Baker BR; Lourens GJ
J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049
[No Abstract] [Full Text] [Related]
14. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
[No Abstract] [Full Text] [Related]
15. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
Baker BR; Lourens GJ
J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
[No Abstract] [Full Text] [Related]
16. Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
Baker BR; Ashton WT
J Med Chem; 1970 Nov; 13(6):1161-5. PubMed ID: 5479857
[No Abstract] [Full Text] [Related]
17. Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
Baker BR; Huang PC
J Med Chem; 1968 May; 11(3):495-500. PubMed ID: 5241409
[No Abstract] [Full Text] [Related]
18. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II.
Baker BR; Vermeulen NM
J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856
[No Abstract] [Full Text] [Related]
19. Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
Baker BR; Meyer RB
J Med Chem; 1968 May; 11(3):489-94. PubMed ID: 5241408
[No Abstract] [Full Text] [Related]
20. Active-site directed irreversible inhibitors of dihydrofolate reductase.
Baker BR
Ann N Y Acad Sci; 1971 Nov; 186():214-26. PubMed ID: 4943574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
